IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2623 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2455    
    Printed103    
    Emailed0    
    PDF Downloaded299    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 

 SHORT COMMUNICATION
Year : 2009  |  Volume : 41  |  Issue : 3  |  Page : 144-147

Role of central muscarinic cholinergic receptors in the formalin-induced pain in rats


Division of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

Correspondence Address:
Esmaeal Tamaddonfard
Division of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.55205

Rights and Permissions

Objectives: In the present study, central effects of physostigmine and atropine have investigated in the formalin-induced pain in rats. Materials and Methods: In conscious rats implanted with an intracerebroventricular (i.c.v.) cannula, the effects of i.c.v. injection of physostigmine and atropine were investigated on the formalin test in the rat. Formalin test was induced by subcutaneous (s.c.) injection of formalin (50 µl, 1%) in ventral surface of left hind paw, and durations of licking and biting of the injected paw were measured in 5-min blocks for 1 h. Results: Formalin produced a biphasic response (first phase: 0-5 and second phase: 15-40 min) in durations of licking and biting of the injected paw. Physostigmine at doses of 2.5, 5 and 10 ug significantly (P < 0.05) attenuated both first and second phases of pain response. Atropine (5 and 10 ug), used alone, produced no significant effect on pain, but pretreatment with atropine (10 ug) significantly (P < 0.05) blocked antinociception induced by physostigmine (5 ug). Conclusion: These results indicate that i.c.v. physostigmine can affect both neurogenic and inflammatory phases of formalin-induced pain through a mechanism in which the muscarinic cholinergic receptors are involved.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow